The page is the record's research on the issuer — no analyst, no rating, no view. # Coya Therapeutics, Inc. (NASDAQ: COYA) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is Coya Therapeutics, Inc., listed on NASDAQ under ticker COYA, with ISIN US22407B1089 and LEI not on the record (no GLEIF record with the exact legal name in jurisdiction US-DE). Its security type is Corporate, its segment is not on the record, its sector is 2834 Pharmaceutical Preparations, and its jurisdiction is United States, Delaware. The issuer is listed, not halted. ## The disclosure read The record holds 43 filings across 23 filing days in the window 2025-11-08 to 2026-11-08. Of these, 11 are directors' dealings, 8 are corporate news, 8 are regulatory filings, 8 are results, 3 are AGM or EGM filings, 3 are prospectuses, and 2 are director changes. The median gap between filing days is 10.0 days, against a NASDAQ median of 6.0 days and a sector median of 6.0 days. Latency from the latest filing to the record date is 25 days, against a NASDAQ median of 5.0 days and a sector median of 4.0 days. The latest filing is corporate news dated 2026-10-14. ## Auditor The auditor of record is Weaver and Tidwell, L.L.P., located in New York, NY. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting, or name change lines. The domicile change is not on the record, since EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, since the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted. ## Orderability The outcome is not determinable, because the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage The issuer's own investor-relations page names 6 research houses: BTIG, Chardan, HC Wainwright & CO, Lakestreet, LUCID, and ROTH. ## Open research No openly published research notes were found on the record. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The record seals issuer years 2021, 2022, 2023, 2024, 2025, and 2026. The market's earliest sealed date is 2021-01-04, and the live record began on 2026-09-12. ## Sources 9 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001835022.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/COYA (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://www.sec.gov/Archives/edgar/data/1835022/000119312526107281/coya-20251231.htm (the auditor) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://ir.coyatherapeutics.com/stock-info/analyst-coverage/default.aspx (coverage) - https://mcp.us-cm-kg.ai/record/NASDAQ/COYA (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/COYA · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp